Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microvision (MVIS) -- Ignore unavailable to you. Want to Upgrade?

To: bob who wrote (2652)	5/24/1999 8:16:00 AM
From: kili	Respond to of 7720

Good work MVIS! You're spoiling us! Kim

To: bob who wrote (2652)	5/24/1999 9:15:00 AM
From: Josef Svejk	Read Replies (1) \| Respond to of 7720

Humble thanks, bob, seems like Day #3 should be no problem. :-) Cheers, Svejk proofsheet.com

To: bob who wrote (2652)	5/24/1999 12:44:00 PM
From: Dee Jay	Read Replies (1) \| Respond to of 7720

WHOOOEEEEEEE!!! YAHOOOO!!!! etc. Dee Jay

To: bob who wrote (2652)	5/27/1999 7:23:00 AM
From: bob	Read Replies (1) \| Respond to of 7720

Microvision Adds Patents to Growing Portfolio BOTHELL, Wash., May 27 /PRNewswire/ -- Microvision, Inc. (Nasdaq: MVIS, MVISW) today announced that the United States Patent Office has issued one new patent and allowed two others surrounding the company's Virtual Retinal Display(TM) (VRD(TM)) technology and related scanning technology. The company also announced that it has secured exclusive rights, through a license with Stanford University's Office of Technology Licensing, to one issued patent and two pending patent applications relating to the design and fabrication of novel micro electro-mechanical (MEMs) devices. The newly-licensed patents and applications describe proprietary techniques for building optical devices using MEMs scanners and novel approaches to integrating electrical structures into MEMs devices. The Stanford patents combined with MEMs patents previously licensed by Microvision cover a variety of design approaches for both uniaxial and biaxial MEMs devices and structures. "In addition to our ongoing development of patented technology for scanned-beam displays, imaging system and optical sensors, we are establishing a strong proprietary position in MEMs technology," said Casey Tegreene, Microvision's intellectual property counsel. "These rights are a powerful addition to the company's growing portfolio of intellectual property (IP)." "We are amassing a technology base that is increasingly attractive to a number of existing and potential customers interested not only in advanced electronic displays but in all forms of electronic and digital imaging," added Will McAllister, Microvision's Vice President of Marketing. With the newly issued patents, licenses and patent applications, Microvision now holds exclusive rights to 15 issued patents and 42 pending U.S. patent applications. Additionally, Microvision holds exclusive rights to a number of non-U.S. patent applications. The company's heavily-patented Virtual Retinal Display(TM) (VRD(TM)) technology promises unprecedented performance in personal display for aerospace, defense, medical and industrial customers, and affordable micro-display solutions for consumer products. About Microvision Headquartered in Bothell, Wash., Microvision, Inc. (Nasdaq: MVIS, MVISW) is the developer of the patented Virtual Retinal Display(TM) (VRD(TM)) technology that uses a rapidly scanned beam of light to project images on the eye's retina, allowing the viewer to see large, full-motion images without the need for a conventional display screen. Microvision's objective is to be a leading provider of personal display products and imaging technology in a broad range of military, medical, industrial, professional and consumer applications. The company was founded in 1993. Additional information can be found at the company's website at mvis.com. Forward-Looking Statement The information set forth in this release includes "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by those sections. Certain factors that realistically could cause results to differ materially from those projected in the company's forward-looking statements are set forth in the company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission. SOURCE Microvision, Inc. Web Site: mvis.com